MODALITY
saveBi-specific T-cell engager (BiTE)
T-cell engagers redirecting T cells to tumor antigens.
also known as: bite, bispecific t-cell engager
drugs
0
catalysts
0
news
8
companies
0
Top drugs
no drugs tagged with this interest yet
🐶 Top companies
no companies tagged with this interest yet
Recent catalysts
no catalysts tagged with this interest yet
Recent news
view all →- CDC releases latest life expectancy datastat · 13h ago
- Regeneron ends eye disease trial for anti-CD3 antibody following safety reviewfiercebiotech · 8d ago
- Context scraps bispecific T-cell engager program to extend cash runway deeper into 2027fiercebiotech · 19d ago
- Roche drops TCE for lupus, but hasn’t given up on autoimmune cell therapiesfiercebiotech · 1mo ago
comments(0)
5-min edit window · permanent after that